BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16040623)

  • 1. Invasive Candida species infections: a 5 year population-based assessment.
    Laupland KB; Gregson DB; Church DL; Ross T; Elsayed S
    J Antimicrob Chemother; 2005 Sep; 56(3):532-7. PubMed ID: 16040623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility patterns of Candida species recovered from Canadian intensive care units.
    Laverdiere M; Labbé AC; Restieri C; Rotstein C; Heyland D; Madger S; Stewart T
    J Crit Care; 2007 Sep; 22(3):245-50. PubMed ID: 17869976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
    Parkins MD; Sabuda DM; Elsayed S; Laupland KB
    J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
    Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
    Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive Candida infections in children: the clinical characteristics and species distribution and antifungal susceptibility of Candida spp.
    Belet N; Ciftçi E; Aysev D; Güriz H; Uysal Z; Taçyildiz N; Atasay B; Doğu F; Kendirli T; Kuloğlu Z; Ince E; Doğru U
    Turk J Pediatr; 2011; 53(5):489-98. PubMed ID: 22272448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
    Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
    Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA; Diekema DJ; Colombo AL; Kibbler C; Ng KP; Gibbs DL; Newell VA
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.